Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism.
Sewastianik T, Szydlowski M, Jablonska E, Bialopiotrowicz E, Kiliszek P, Gorniak P, Polak A, Prochorec-Sobieszek M, Szumera-Cieckiewicz A, Kaminski TS, Markowicz S, Nowak E, Grygorowicz MA, Warzocha K, Juszczynski P. Sewastianik T, et al. Oncogene. 2016 Nov 17;35(46):5989-6000. doi: 10.1038/onc.2016.126. Epub 2016 May 2. Oncogene. 2016. PMID: 27132507
Distribution of lymphomas in Poland according to World Health Organization classification: analysis of 11718 cases from National Histopathological Lymphoma Register project - the Polish Lymphoma Research Group study.
Szumera-Ciećkiewicz A, Gałązka K, Szpor J, Rymkiewicz G, Jesionek-Kupnicka D, Gruchała A, Ziarkiewicz-Wróblewska B, Poniatowska-Broniek G, Demczuk S, Prochorec-Sobieszek M. Szumera-Ciećkiewicz A, et al. Int J Clin Exp Pathol. 2014 May 15;7(6):3280-6. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25031749 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34701013
Minimally Invasive Plasma Device Management of Multiple Benign Skin Cancers Associated with Rare Genodermatoses-Case Series and Review of the Therapeutic Methods.
Płatkowska A, Słowińska M, Zalewska J, Swacha Z, Szumera-Ciećkiewicz A, Wągrodzki M, Patera J, Łapieńska-Rey K, Lorent M, Ługowska I, Rutkowski P, Owczarek W. Płatkowska A, et al. Among authors: szumera cieckiewicz a. J Clin Med. 2024 Jul 26;13(15):4377. doi: 10.3390/jcm13154377. J Clin Med. 2024. PMID: 39124644 Free PMC article.
Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.
Chmiel P, SłOWIKOWSKA A, Banaszek Ł, Szumera-CIEćKIEWICZ A, Szostakowski B, SPAłEK MJ, Świtaj T, Rutkowski P, Czarnecka AM. Chmiel P, et al. Among authors: szumera cieckiewicz a. Oncol Res. 2024 Jun 20;32(7):1141-1162. doi: 10.32604/or.2024.050350. eCollection 2024. Oncol Res. 2024. PMID: 38948020 Free PMC article. Review.
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.
Bobrowicz M, Kusowska A, Krawczyk M, Zhylko A, Forcados C, Slusarczyk A, Barankiewicz J, Domagala J, Kubacz M, Šmída M, Dostalova L, Marhelava K, Fidyt K, Pepek M, Baranowska I, Szumera-Cieckiewicz A, Inderberg EM, Wälchli S, Granica M, Graczyk-Jarzynka A, Majchrzak M, Poreba M, Gehlert CL, Peipp M, Firczuk M, Prochorec-Sobieszek M, Winiarska M. Bobrowicz M, et al. Among authors: szumera cieckiewicz a. Oncoimmunology. 2024 Jun 4;13(1):2362454. doi: 10.1080/2162402X.2024.2362454. eCollection 2024. Oncoimmunology. 2024. PMID: 38846084 Free PMC article.
Long-term efficacy of neoadjuvant-adjuvant targeted therapy in borderline resectable stage IIIB-D and IV melanoma.
Czarnecka AM, Ostaszewski K, Błoński PJ, Szumera-Ciećkiewicz A, Świtaj T, Kozak K, Koseła-Patreczyk H, Rogala P, Kalinowska I, Zaborowski K, Krotewicz M, Borkowska A, Rutkowski P. Czarnecka AM, et al. Among authors: szumera cieckiewicz a. Cancer. 2024 Oct 15;130(20):3463-3472. doi: 10.1002/cncr.35425. Epub 2024 Jun 6. Cancer. 2024. PMID: 38843386
101 results